Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
434.40 DKK | +0.36% |
|
+1.28% | -30.41% |
May. 15 | Abbott India's quarterly profit climbs 28% on strong demand | RE |
May. 15 | Waters Sees Surge in India Demand as Drugmakers Race to Develop Weight-Loss Drug Generics | MT |
Chart calendar Novo Nordisk A/S
17b7c27425416581bbad694a.Fy_jxZlFPnC4LZAaYrmfYkODTi06ZUg4vOmFTffUNok.L1jO9v8aeynTfvgtJOOvAw7SCRtZEjx6_r_GO6PnTNluVqrwz3Z_HJVIoA~c32d24ab0c1a6bc5cca8bd469ed09a43
Upcoming events on Novo Nordisk A/S
Past events on Novo Nordisk A/S
Past dividends on Novo Nordisk A/S
2025-03-27 | Final Payment 7.9 DKK |
2024-08-14 | Interim Payment 3.5 DKK |
2024-03-21 | Final Payment 6.4 DKK |
2023-08-17 | Interim Payment 6 DKK |
2023-03-23 | Final Payment 8.15 DKK |
2022-08-11 | Interim Payment 4.25 DKK |
2022-03-24 | Final Payment 6.9 DKK |
2021-08-15 | Interim Payment 3.5 DKK |
2021-03-25 | Final Payment 5.85 DKK |
2020-08-13 | Interim Payment 3.25 DKK |
2020-03-26 | Final Payment 5.35 DKK |
2019-08-15 | Interim Payment 3 DKK |
2019-03-21 | Final Payment 5.15 DKK |
2018-08-16 | Interim Payment 3 DKK |
2018-03-22 | Final Payment 4.85 DKK |
2017-08-17 | Interim Payment 3 DKK |
2017-03-23 | Final Payment 4.6 DKK |
2016-08-11 | Interim Payment 3 DKK |
2016-03-20 | Annual 6.4 DKK |
2015-03-19 | 5 DKK |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million DKK | Released Forecast Spread | 176 954 175 090 1.06% | 232 261 228 920 1.46% | 290 403 285 429 1.74% | 337 488 | 389 643 | 432 187 |
EBITDA Million DKK | Released Forecast Spread | 82 171 82 386 -0.26% | 111 987 109 530 2.24% | 147 446 141 939 3.88% | 170 867 | 201 076 | 225 224 |
EBIT Million DKK | Released Forecast Spread | 74 809 75 141 -0.44% | 102 574 101 255 1.3% | 128 339 126 210 1.69% | 154 248 | 181 320 | 201 377 |
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 69 062 69 370 -0.44% | 104 674 102 184 2.44% | 127 191 125 432 1.4% | 148 666 | 178 745 | 197 640 |
Net income Million DKK | Released Forecast Spread | 55 525 54 785 1.35% | 83 683 82 021 2.03% | 100 988 100 215 0.77% | 117 634 | 141 608 | 157 694 |
EPS DKK | Released Forecast Spread | 12,2 12,2 0.25% | 18,6 18,3 1.79% | 22,6 22,3 1.67% | 26,4 | 31,8 | 35,7 |
Announcement Date | 01/02/23 | 31/01/24 | 05/02/25 | - |
Quarterly results
Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million DKK | Released Forecast Spread | 58 731 57 395 2.33% | 65 863 61 207 7.61% | 65 349 63 437 3.01% | 68 060 68 563 -0.73% | 71 311 71 869 -0.78% | 85 683 80 179 6.86% | 78 087 78 019 0.09% | 77 786 | 83 219 | 92 912 | 91 893 | 96 564 | 97 695 | 104 300 |
EBITDA Million DKK | Released Forecast Spread | 29 438 27 843 5.73% | 29 758 27 194 9.43% | 34 760 31 300 11.05% | 34 779 29 430 18.17% | 35 972 36 184 -0.59% | 41 935 36 501 14.89% | 42 621 40 715 4.68% | 38 185 | 41 647 | 42 133 | 43 390 | 35 790 | ||
EBIT Million DKK | Released Forecast Spread | 26 913 25 565 5.27% | 26 766 25 489 5.01% | 31 846 28 694 10.99% | 25 934 27 258 -4.86% | 33 822 33 301 1.57% | 36 737 32 939 11.53% | 38 791 36 740 5.58% | 34 604 | 38 110 | 39 466 | 38 791 | 30 658 | ||
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 28 063 26 623 5.41% | 27 620 25 972 6.34% | 31 918 28 630 11.48% | 25 332 27 740 -8.68% | 34 384 33 325 3.18% | 35 557 31 782 11.88% | 37 033 35 000 5.81% | 30 973 | 34 470 | 40 247 | 37 033 | 30 626 | ||
Net income Million DKK | Released Forecast Spread | 22 478 21 592 4.1% | 21 963 20 717 6.01% | 25 407 23 169 9.66% | 20 050 22 116 -9.34% | 27 301 26 877 1.58% | 28 230 25 680 9.93% | 29 034 27 298 6.36% | 25 950 | 29 113 | 32 672 | 31 289 | 29 030 | 36 902 | 36 181 |
EPS DKK | Released Forecast Spread | 5,00 4,50 11.05% | 4,91 4,59 7.08% | 5,68 5,19 9.54% | 4,49 4,71 -4.72% | 6,12 5,98 2.32% | 6,34 5,76 10.01% | 6,53 6,15 6.1% | 5,88 | 6,53 | 7,35 | 7,03 | 6,52 | 8,28 | 8,12 |
Announcement Date | 02/11/23 | 31/01/24 | 02/05/24 | 07/08/24 | 06/11/24 | 05/02/25 | 07/05/25 | - | - | - | - | - | - | - |
More events
Past sector events for Novo Nordisk A/S
Today | JUBILANT PHARMOVA LIMITED: Q4 2025 Earnings Release |
2025-05-14 | NEULAND LABORATORIES LIMITED: Q4 2025 Earnings Release |
2025-05-14 | ALIVUS LIFE SCIENCES LIMITED: Q4 2025 Earnings Release |
2025-05-14 | EISAI CO., LTD.: Q4 2024 Earnings Release |
2025-05-14 | TOWA PHARMACEUTICAL CO., LTD.: Q4 2024 Earnings Release |
2025-05-14 | DERMAPHARM HOLDING SE: Q1 2025 Earnings Release |
2025-05-14 | CAMURUS AB: Q1 2025 Earnings Release |
2025-05-14 04:52 am | HIKAL LIMITED: Q4 2025 Earnings Release |
2025-05-14 04:40 am | BLUE JET HEALTHCARE LIMITED: Q4 2025 Earnings Release |
2025-05-14 03:35 am | SAI LIFE SCIENCES LIMITED: Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
- Calendar Novo Nordisk A/S
Select your edition
All financial news and data tailored to specific country editions